Sponsors (3)
The bill aims to accelerate pediatric cancer research and trials and improve health-data interoperability through federal coordination and multi-year funding for AI initiatives, while raising significant privacy/civil‑liberty and AI-safety risks and increasing federal spending.
Children with cancer and related patients: AI-coordinated research and trials could accelerate development of better diagnostics and treatments and make clinical trials more efficient and accessible.
Hospitals and researchers: Federal integration of AI into health data standards could make research-ready data more interoperable while aiming to protect privacy.
Researchers and health systems: A federal coordination role can help align agency efforts to speed translation of academic and private-sector AI innovations into pediatric cancer care.
Patients (including children) and families: Centralizing and consolidating health data for AI raises risks to privacy and reidentification and could enable increased government access to sensitive health information if governance and safeguards are inadequate.
Children with cancer and clinical providers: Expanding AI into clinical decision-making and trial design could produce biased or inaccurate recommendations without robust validation and oversight, risking patient safety.
Taxpayers and budget priorities: The additional federal spending authorized increases taxpayer costs and could reprioritize or crowd out funding for other health programs.
Based on analysis of 2 sections of legislative text.
Creates a federal AI coordinator for pediatric cancer, requires AI-ready data standards in HHS interoperability work, and authorizes funding for CCDI AI activities (FY2027–2031).
Official title: To better coordinate Federal efforts to utilize advance technologies, such as AI, to improve diagnoses, treatments, cures, and prevention strategies for pediatric cancer, and for other purposes.
Introduced July 9, 2026 by Michael T. McCaul · Last progress July 9, 2026
Creates a federal coordinator to lead and coordinate use of advanced technologies, including artificial intelligence, to speed improvements in diagnosis, treatment, prevention, and cures for childhood cancer. Directs the coordinator to work with HHS and the Childhood Cancer Data Initiative (CCDI) to identify AI opportunities, strengthen data infrastructure, and improve clinical trial design and outcomes. Requires HHS to incorporate AI into interoperability efforts, finalize standards for AI-usable patient data (covering structured and unstructured data and privacy/safety measures), and deliver a report to specified congressional committees within 180 days. Authorizes unspecified sums for FY2027–2031 and separately authorizes up to $100 million per year for CCDI-related activities for FY2027–2031.